3DLinker: An E(3) Equivariant Variational Autoencoder for Molecular Linker Design
원문 초록
Deep learning has achieved tremendous success in designing novel chemical compounds with desirable pharmaceutical properties. In this work, we focus on a new type of drug design problem -- generating a small "linker" to physically attach two independent molecules with their distinct functions. The main computational challenges include: 1) the generation of linkers is conditional on the two given molecules, in contrast to generating full molecules from scratch in previous works; 2) linkers heavily depend on the anchor atoms of the two molecules to be connected, which are not known beforehand; 3) 3D structures and orientations of the molecules need to be considered to avoid atom clashes, for which equivariance to E(3) group are necessary. To address these problems, we propose a conditional generative model, named 3DLinker, which is able to predict anchor atoms and jointly generate linker graphs and their 3D structures based on an E(3) equivariant graph variational autoencoder. So far as we know, there are no previous models that could achieve this task. We compare our model with multiple conditional generative models modified from other molecular design tasks and find that our model has a significantly higher rate in recovering molecular graphs, and more importantly, accurately predicting the 3D coordinates of all the atoms.
함께 살펴볼 논문
공통 태그를 근거로 연결했습니다. 실제 인용 관계나 논문의 우수성을 뜻하지 않습니다.
Assay2Mol: large language model-based drug design using BioAssay context
TABASCO: A Fast, Simplified Model for Molecular Generation with Improved Physical Quality
CovDocker: Benchmarking Covalent Drug Design with Tasks, Datasets, and Solutions
Scalable and Cost-Efficient de Novo Template-Based Molecular Generation
UniSite: The First Cross-Structure Dataset and Learning Framework for End-to-End Ligand Binding Site Detection
Bridging Quantum and Classical Computing in Drug Design: Architecture Principles for Improved Molecule Generation
토론
이 논문과 연결된 포럼 글이 아직 없습니다.